Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Heterogeneity of Coenzyme Q10Deficiency

Heterogeneity of Coenzyme Q10Deficiency NEUROLOGICAL REVIEW Heterogeneity of Coenzyme Q Deficiency Patient Study and Literature Review Valentina Emmanuele, MD; Luis C. Lo´pez, PhD; Andres Berardo, MD; Ali Naini, PhD; Saba Tadesse, BS; Bing Wen, MD; Erin D’Agostino, BA; Martha Solomon, BA; Salvatore DiMauro, MD; Catarina Quinzii, MD; Michio Hirano, MD oenzyme Q (CoQ ) deficiency has been associated with 5 major clinical pheno- 10 10 types: encephalomyopathy, severe infantile multisystemic disease, nephropathy, cer- ebellar ataxia, and isolated myopathy. Primary CoQ deficiency is due to defects in C CoQ biosynthesis, while secondary forms are due to other causes. A review of 149 cases, including our cohort of 76 patients, confirms that CoQ deficiency is a clinically and ge- netically heterogeneous syndrome that mainly begins in childhood and predominantly manifests as cerebellar ataxia. Coenzyme Q measurement in muscle is the gold standard for diagnosis. Iden- tification of CoQ deficiency is important because the condition frequently responds to treat- ment. Causative mutations have been identified in a small proportion of patients. Arch Neurol. 2012;69(8):978-983. Published online April 9, 2012. doi:10.1001/archneurol.2012.206 creased in 1 member of the family with similar Coenzyme Q (CoQ or ubiquinone) de- 10 10 phenotype and/or genetic mutation were con- ficiency in humans http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Heterogeneity of Coenzyme Q10Deficiency

Download PDF
6 pages
Read Article

Loading next page...
 
/lp/american-medical-association/heterogeneity-of-coenzyme-q10deficiency-FGtMJ2VwvH
Publisher
American Medical Association
Copyright
Copyright 2012 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/archneurol.2012.206
pmid
22490322
Publisher site
See Article on Publisher Site

Abstract

NEUROLOGICAL REVIEW Heterogeneity of Coenzyme Q Deficiency Patient Study and Literature Review Valentina Emmanuele, MD; Luis C. Lo´pez, PhD; Andres Berardo, MD; Ali Naini, PhD; Saba Tadesse, BS; Bing Wen, MD; Erin D’Agostino, BA; Martha Solomon, BA; Salvatore DiMauro, MD; Catarina Quinzii, MD; Michio Hirano, MD oenzyme Q (CoQ ) deficiency has been associated with 5 major clinical pheno- 10 10 types: encephalomyopathy, severe infantile multisystemic disease, nephropathy, cer- ebellar ataxia, and isolated myopathy. Primary CoQ deficiency is due to defects in C CoQ biosynthesis, while secondary forms are due to other causes. A review of 149 cases, including our cohort of 76 patients, confirms that CoQ deficiency is a clinically and ge- netically heterogeneous syndrome that mainly begins in childhood and predominantly manifests as cerebellar ataxia. Coenzyme Q measurement in muscle is the gold standard for diagnosis. Iden- tification of CoQ deficiency is important because the condition frequently responds to treat- ment. Causative mutations have been identified in a small proportion of patients. Arch Neurol. 2012;69(8):978-983. Published online April 9, 2012. doi:10.1001/archneurol.2012.206 creased in 1 member of the family with similar Coenzyme Q (CoQ or ubiquinone) de- 10 10 phenotype and/or genetic mutation were con- ficiency in humans

Journal

JAMA Neurology – American Medical Association

Published: Aug 1, 2012

References

  • Primary and secondary CoQ(10) deficiencies in humans.
    Quinzii, CM; Hirano, M
  • Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy.
    Ogasahara, S; Engel, AG; Frens, D; Mack, D
  • Mitochondrial encephalomyopathy with coenzyme Q10 deficiency.
    Sobreira, C; Hirano, M; Shanske, S
  • Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency.
    Di Giovanni, S; Mirabella, M; Spinazzola, A
  • Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency.
    Lalani, SR; Vladutiu, GD; Plunkett, K; Lotze, TE; Adesina, AM; Scaglia, F
  • Coenzyme Q10 deficiency and isolated myopathy.
    Horvath, R; Schneiderat, P; Schoser, BG
  • The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene.
    Gempel, K; Topaloglu, H; Talim, B
  • Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations.
    López, LC; Schuelke, M; Quinzii, CM
  • A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease.
    Duncan, AJ; Bitner-Glindzicz, M; Meunier, B
  • Neonatal liver failure and Leigh syndrome possibly due to CoQ-responsive OXPHOS deficiency.
    Leshinsky-Silver, E; Levine, A; Nissenkorn, A
  • A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency.
    Quinzii, C; Naini, A; Salviati, L
  • COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement.
    Diomedi-Camassei, F; Di Giandomenico, S; Santorelli, FM
  • Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency.
    Montini, G; Malaventura, C; Salviati, L
  • COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness.
    Heeringa, SF; Chernin, G; Chaki, M
  • Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.
    Rötig, A; Appelkvist, EL; Geromel, V
  • Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders.
    Mollet, J; Giurgea, I; Schlemmer, D
  • ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency.
    Lagier-Tourenne, C; Tazir, M; López, LC
  • A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency.
    Boitier, E; Degoul, F; Desguerre, I
  • Familial cerebellar ataxia with muscle coenzyme Q10 deficiency.
    Musumeci, O; Naini, A; Slonim, AE
  • Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation.
    Quinzii, CM; Kattah, AG; Naini, A
  • Cerebellar ataxia and coenzyme Q10 deficiency.
    Lamperti, C; Naini, A; Hirano, M
  • Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency.
    Gironi, M; Lamperti, C; Nemni, R
  • Progression despite replacement of a myopathic form of coenzyme Q10 defect.
    Auré, K; Benoist, JF; Ogier de Baulny, H; Romero, NB; Rigal, O; Lombès, A
  • CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures.
    Mollet, J; Delahodde, A; Serre, V
  • Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation.
    Artuch, R; Brea-Calvo, G; Briones, P
  • Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1.
    Le Ber, I; Dubourg, O; Benoist, JF
  • Ataxia with oculomotor apraxia type 1 (AOA1): clinical and neuropsychological features in 2 new patients and differential diagnosis.
    D’Arrigo, S; Riva, D; Bulgheroni, S
  • Nonsense mutations in CABC1/ADCK3 cause progressive cerebellar ataxia and atrophy.
    Gerards, M; van den Bosch, B; Calis, C
  • Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.
    Castellotti, B; Mariotti, C; Rimoldi, M
  • Coenzyme Q(10)-responsive ataxia: 2-year-treatment follow-up.
    Pineda, M; Montero, R; Aracil, A
  • The use of muscle biopsy in the diagnosis of undefined ataxia with cerebellar atrophy in children [published online August 26, 2011].
    Terracciano, A; Renaldo, F; Zanni, G
  • Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3.
    Horvath, R; Czermin, B; Gulati, S
  • Neonatal presentation of coenzyme Q10 deficiency.
    Rahman, S; Hargreaves, I; Clayton, P; Heales, S
  • Coenzyme Q-responsive Leigh's encephalopathy in two sisters.
    Van Maldergem, L; Trijbels, F; DiMauro, S
  • Cardiofaciocutaneous (CFC) syndrome associated with muscular coenzyme Q10 deficiency.
    Aeby, A; Sznajer, Y; Cavé, H
  • Hypotonia and infantile spasms: a new phenotype of coenzyme Q10 deficiency?
    Huntsman, RJ; Lemire, EG; Dunham, CP

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$499/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

Sign up
for free
Start 14 day
Free Trial